NovoCure LimitedNVCRNASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending higher, below historical average, slight contraction.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-69.22M
↓ 142% below average
Average (9y)
$-28.58M
Historical baseline
Range
High:$84.18M
Low:$-125.26M
CAGR
-5.0%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | $-69.22M | +31.1% |
| 2023 | $-100.43M | -1165.0% |
| 2022 | $9.43M | -83.9% |
| 2021 | $58.59M | -30.4% |
| 2020 | $84.18M | +421.7% |
| 2019 | $16.14M | +288.1% |
| 2018 | $-8.58M | +78.8% |
| 2017 | $-40.50M | +67.7% |
| 2016 | $-125.26M | -13.7% |
| 2015 | $-110.16M | - |